Literature DB >> 16849344

Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease.

N Kawada1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16849344      PMCID： PMC1856264          DOI： 10.1136/gut.2005.090449

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  19 in total

1.  Is liver fibrosis reversible?

Authors:  P A Bonis; S L Friedman; M M Kaplan
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 2.  Cirrhosis reversal: a duel between dogma and myth.

Authors:  Valeer J Desmet; Tania Roskams
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

Review 3.  Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction.

Authors:  Jagan R Muppidi; Jürg Tschopp; Richard M Siegel
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

4.  Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy.

Authors:  Y Shiratori; F Imazeki; M Moriyama; M Yano; Y Arakawa; O Yokosuka; T Kuroki; S Nishiguchi; M Sata; G Yamada; S Fujiyama; H Yoshida; M Omata
Journal:  Ann Intern Med       Date:  2000-04-04       Impact factor: 25.391

5.  Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Authors:  Frank R Murphy; Razao Issa; Xiaoying Zhou; Shabna Ratnarajah; Hideaki Nagase; Michael J P Arthur; Christopher Benyon; John P Iredale
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

6.  Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.

Authors:  Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Ryuichi Noguchi; Toshiya Nakatani; Hirohisa Tsujinoue; Koji Yanase; Tadashi Namisaki; Hiroo Imazu; Hiroshi Fukui
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

7.  Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.

Authors:  M C Wright; R Issa; D E Smart; N Trim; G I Murray; J N Primrose; M J Arthur; J P Iredale; D A Mann
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

8.  Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

Authors:  E Novo; F Marra; E Zamara; L Valfrè di Bonzo; L Monitillo; S Cannito; I Petrai; A Mazzocca; A Bonacchi; R S M De Franco; S Colombatto; R Autelli; M Pinzani; M Parola
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

9.  Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation.

Authors:  N Trim; S Morgan; M Evans; R Issa; D Fine; S Afford; B Wilkins; J Iredale
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 10.  Liver fibrosis: from the bench to clinical targets.

Authors:  M Pinzani; K Rombouts
Journal:  Dig Liver Dis       Date:  2004-04       Impact factor: 4.088
View more
  13 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

Review 2.  Cell death and fibrogenesis.

Authors:  Wajahat Mehal; Avlin Imaeda
Journal:  Semin Liver Dis       Date:  2010-07-21       Impact factor: 6.115

3.  Bone marrow stromal cells control the growth of hepatic stellate cells in vitro.

Authors:  Lijun Shi; Guozhong Li; Jinghua Wang; Bo Sun; Liming Yang; Guangyou Wang; Dandan Wang; Lili Mu; Hui Chen; Lianhong Jin; Nikolaos Kostulas; Hulun Li
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

4.  A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1).

Authors:  Xinghua Lin; Hong Yang; Hongfeng Zhang; LiChun Zhou; ZhongMao Guo
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

5.  Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways.

Authors:  Joy X Jiang; Kenichiro Mikami; Senthil Venugopal; Yong Li; Natalie J Török
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

6.  The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.

Authors:  Mahmoud Elshal; Nashwa Abu-Elsaad; Amr El-Karef; Tarek Mostafa Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-14       Impact factor: 3.000

7.  Sedum mexicanum Britt. Induces Apoptosis of Primary Rat Activated Hepatic Stellate Cells.

Authors:  Shou-Lun Lee; Ting-Yu Chin; Ching-Long Lai; Wen-Han Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-20       Impact factor: 2.629

Review 8.  Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development.

Authors:  Li Hu; Huiqin Li; Meiting Zi; Wen Li; Jing Liu; Yang Yang; Daohong Zhou; Qing-Peng Kong; Yunxia Zhang; Yonghan He
Journal:  Front Cell Dev Biol       Date:  2022-02-16

9.  Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells.

Authors:  Alessandra Gentilini; Benedetta Lottini; Marco Brogi; Alessandra Caligiuri; Lorenzo Cosmi; Fabio Marra; Massimo Pinzani
Journal:  Fibrogenesis Tissue Repair       Date:  2009-01-30

10.  Dose-Dependent Antifibrotic Effect of Chrysin on Regression of Liver Fibrosis: The Role in Extracellular Matrix Remodeling.

Authors:  Cornel Balta; Alina Ciceu; Hildegard Herman; Marcel Rosu; Oana Maria Boldura; Anca Hermenean
Journal:  Dose Response       Date:  2018-08-08       Impact factor: 2.658
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.